Friends Of Cancer Research
- Assets
- $13.4m
- Revenue
- $6.8m
- Investments
- $0.0
- Employees
- 13
- Location
- Washington, DC
- Founding
- 09/1996
- Data as of
- 12/2022
- EIN
- 52-1983273
Organization Overview
Friends Of Cancer Research is located in Washington, DC. The organization was established in 1996. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Friends Of Cancer Research employed 13 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Friends Of Cancer Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Friends Of Cancer Research generated $6.8m in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 10.2% each year . All expenses for the organization totaled $5.0m during the year ending 12/2022. While expenses have increased by 8.8% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Friends Of Cancer Research has awarded 32 individual grants totaling $329,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO DRIVE COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SCIENCE POLICY: FRIENDS OF CANCER RESEARCH DRIVES COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS.
MEETINGS AND PROFESSIONAL DEVELOPMENT: FRIENDS OF CANCER RESEARCH BRINGS TOGETHER LEADERS IN CANCER DRUG DEVELOPMENT, FEDERAL HEALTH AND REGULATORY AGENCIES, ACADEMIC RESEARCH, THE PRIVATE SECTOR, AND PATIENT ADVOCATES FOR FOCUSED DISCUSSIONS ON KEY ISSUES SURROUNDING THE DEVELOPMENT AND REGULATION OF CANCER DRUGS AND THERAPIES.
COMMUNICATION: THE ORGANIZATION PROVIDES INDEPTH COVERAGE OF THE EVENTS, TRENDS, AND ISSUES THAT AFFECT THE PUBLIC HEALTHCARE INDUSTRY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jeff Allen PHD President & CEO | OfficerTrustee | 40 | $622,957 |
Ryan Hohman JD Vp-Public Affairs | 40 | $285,934 | |
Mark Stewart PHD Vp-Science Policy | 40 | $258,113 | |
Heather Chaney Vp-Operations | 40 | $207,967 | |
Hillary Andrews Dir.-Reg & Res Par | 40 | $161,668 | |
Linda Ostermann Dir.-Grant & Oper | 40 | $150,093 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Cancer Research And Biostat Project Consulting | 12/30/23 | $109,191 |
Sandi R Hoffman Llc Consulting | 12/30/23 | $178,024 |
Lydon Fetterolf Corydon Pa Accounting | 12/30/23 | $120,099 |
Four Moon Productions Media/audio/broadcasting | 12/30/23 | $270,555 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $6,455,557 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $6,455,557 |
| Total Program Service Revenue | $0 |
| Investment income | $339,036 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$10,060 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $6,784,533 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,439,227 |
| Compensation of current officers, directors, key employees. | $225,448 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $829,938 |
| Pension plan accruals and contributions | $20,840 |
| Other employee benefits | $28,602 |
| Payroll taxes | $130,342 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $27,187 |
| Fees for services: Accounting | $115,405 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $52,853 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $108,987 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $363,515 |
| Travel | $32,634 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $1,195,797 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $41,922 |
| Insurance | $0 |
| All other expenses | $75,283 |
| Total functional expenses | $4,975,120 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,187,436 |
| Savings and temporary cash investments | $537,611 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $83,956 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $96,262 |
| Net Land, buildings, and equipment | $218,583 |
| Investments—publicly traded securities | $10,447,978 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $808,725 |
| Total assets | $13,380,551 |
| Accounts payable and accrued expenses | $218,941 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $924,072 |
| Total liabilities | $1,143,013 |
| Net assets without donor restrictions | $11,450,041 |
| Net assets with donor restrictions | $787,497 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $13,380,551 |
Grants Awarded
Over the last fiscal year, Friends Of Cancer Research has awarded $30,000 in support to 3 organizations.
| Grant Recipient | Amount |
|---|---|
FDN FOR NATL INST OF HEALTH PURPOSE: ANNUAL CONTRIBUTION | $10,000 |
JOHNS HOPKINS UNIVERSITY PURPOSE: ANNUAL CONTRIBUTION | $10,000 |
REAGAN UDALL FOUNDATION GALA PURPOSE: ANNUAL CONTRIBUTION | $10,000 |